title: Stability studies on diloxanide furoate: effect of pH, temperature, gastric and intestinal fluids.
abstract: The degradation of the amoebicide diloxanide furoate in alkaline medium at different temperatures was investigated using both a spectrophotometric and a developed HPLC method. In solutions, the drug was found to undergo decomposition, i.e., temperature and pH dependent. The pH-rate profile at pH between 7.6 and 9.6 indicated a first-order dependence of Kobs on [-OH]. Arrhenius plot obtained at pH 8 was linear between 40 and 63 degrees C. The estimated activation energy of hydrolysis was found to be 18.25 kcal degree.mol(-1). The effect of simulated gastric and intestinal fluids on the drug was also investigated. A new thin-layer chromatographic (TLC) procedure for the fractionation of the drug and its alkaline hydrolysis products has been developed and was found to compare favorably with that of the British Pharmacopoeia. Three hydrolysis products of a basic methanolic solution of the drug, namely furoic acid, diloxanide and methylfuroate could be identified by the use of TLC, HPLC, infrared and mass spectrometry.
authors.affiliation: Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
authors.forename: E A
authors.initials: EA
authors.lastname: Gadkariem
authors.forename: F
authors.initials: F
authors.lastname: Belal
authors.forename: M A
authors.initials: MA
authors.lastname: Abounassif
authors.forename: H A
authors.initials: HA
authors.lastname: El-Obeid
authors.forename: K
authors.initials: K
authors.lastname: E E  Ibrahim
mesh_terms: D004355:Drug Stability; D005663:Furans / Q000032:analysis* / Q000737:chemistry* / Q000493:pharmacokinetics; D005750:Gastric Juice / Q000737:chemistry / Q000502:physiology*; D006863:Hydrogen-Ion Concentration; D007419:Intestinal Secretions / Q000737:chemistry / Q000502:physiology*; D019999:Pharmaceutical Solutions / Q000032:analysis / Q000737:chemistry; D013696:Temperature
chemical_list: D005663:Furans; D019999:Pharmaceutical Solutions; C004932:diloxanide furoate